Although this may not happen today, it should not take long for the market to realise that Group Revenue so far this year is running at 8.0% compared with 7.5% for FY18. So, after stabilising the performance of standalone vets, performance has improved compared with the last update. The market should eventually like the already proven uptick in sales and the stabilisation of costs (with more cost savings predicted), because that should improve EBITDA substantially.
GXL Price at posting:
$4.23 Sentiment: Buy Disclosure: Held